Get the Stockscreener App
186.65
0.54%
-1.0915
Charles River Laboratories International Inc stock is traded at $186.65, with a volume of 517.03K.
It is down -0.54% in the last 24 hours and down -5.59% over the past month.
See More
Previous Close:
$187.74
Open:
$185.28
24h Volume:
517.03K
Relative Volume:
0.75
Market Cap:
$10.63B
Revenue:
$4.08B
Net Income/Loss:
$431.79M
P/E Ratio:
19.79
EPS:
9.43
Net Cash Flow:
$486.92M
1W Performance:
-15.39%
1M Performance:
-5.59%
6M Performance:
-15.74%
1Y Performance:
-1.23%
1-Day Range:
$183.58
$186.99
1-Week Range:
$183.35
$221.60
52-Week Range:
$176.48
$275.00
Charles River Laboratories International Inc Stock (CRL) Company Profile
Name
Charles River Laboratories International Inc
Sector
Industry
Phone
781-222-6000
Address
251 BALLARDVALE ST, WILMINGTON, MA
Compare CRL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
| CRL | 186.65 | 10.63B | 4.08B | 431.79M | 486.92M | 9.43 |
| TMO | 500.27 | 192.46B | 42.37B | 6.14B | 7.78B | 15.26 |
| DHR | 229.63 | 165.90B | 23.74B | 3.89B | 4.98B | 7.93 |
| A | 126.31 | 36.48B | 6.50B | 1.41B | 1.42B | 3.82 |
| IDXX | 421.12 | 34.55B | 3.84B | 866.24M | 792.60M | 9.80 |
| IQV | 190.44 | 34.31B | 15.32B | 1.41B | 1.96B | 5.95 |
Charles River Laboratories International Inc Stock (CRL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-15-24 | Downgrade | Guggenheim | Buy → Neutral |
| Sep-13-23 | Initiated | TD Cowen | Market Perform |
| Jul-10-23 | Downgrade | Citigroup | Buy → Neutral |
| Feb-23-23 | Upgrade | Guggenheim | Neutral → Buy |
| Jan-12-23 | Downgrade | Jefferies | Buy → Hold |
| Sep-30-22 | Upgrade | Jefferies | Hold → Buy |
| Aug-25-22 | Initiated | Credit Suisse | Outperform |
| Aug-04-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| May-24-22 | Initiated | Guggenheim | Neutral |
| Apr-25-22 | Downgrade | Jefferies | Buy → Hold |
| Apr-07-22 | Initiated | Stephens | Overweight |
| Feb-17-22 | Reiterated | BofA Securities | Buy |
| Feb-17-22 | Upgrade | Citigroup | Neutral → Buy |
| Feb-17-22 | Reiterated | Deutsche Bank | Buy |
| Feb-17-22 | Reiterated | Morgan Stanley | Overweight |
| Feb-17-22 | Reiterated | UBS | Buy |
| Aug-05-21 | Resumed | Credit Suisse | Neutral |
| Dec-16-20 | Downgrade | Citigroup | Buy → Neutral |
| Sep-10-20 | Upgrade | Jefferies | Hold → Buy |
| Jul-01-20 | Upgrade | BofA Securities | Neutral → Buy |
| May-13-20 | Upgrade | UBS | Neutral → Buy |
| Apr-21-20 | Downgrade | Jefferies | Buy → Hold |
| Mar-27-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Mar-02-20 | Initiated | Deutsche Bank | Buy |
| Feb-18-20 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Jan-10-20 | Upgrade | Goldman | Neutral → Buy |
| Jan-08-20 | Initiated | Wells Fargo | Overweight |
| Jan-07-20 | Initiated | Citigroup | Buy |
| Oct-18-19 | Downgrade | BofA/Merrill | Buy → Neutral |
| Jun-10-19 | Initiated | SVB Leerink | Outperform |
| Apr-30-19 | Resumed | Evercore ISI | Outperform |
| Dec-14-18 | Initiated | Deutsche Bank | Buy |
| Oct-09-18 | Initiated | UBS | Neutral |
| Aug-23-18 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jul-17-18 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Jun-15-18 | Upgrade | KeyBanc Capital Mkts | Sector Weight → Overweight |
| Feb-14-18 | Upgrade | SunTrust | Hold → Buy |
View All
Charles River Laboratories International Inc Stock (CRL) Latest News
Layoff Tracker: Gilead Sciences Will Lay Off 104 Employees at California HQ - BioSpace
Mawer Investment Management Ltd. Sells 32,693 Shares of Charles River Laboratories International, Inc. (NYSE:CRL) - MarketBeat
Charles River Laboratories International (NYSE:CRL) Rating Lowered to Underperform at CLSA - MarketBeat
Charles River Laboratories International, Inc. (NYSE:CRL) Shares Acquired by Sumitomo Mitsui Trust Group Inc. - MarketBeat
Mizuho Securities USA LLC Buys 92,895 Shares of Charles River Laboratories International, Inc. (NYSE:CRL) - MarketBeat
Charles River Laboratories International, Inc. (NYSE:CRL) Shares Sold by KBC Group NV - MarketBeat
Charles River Labs closes several locations, 1,300+ jobs cut in cost saving initiative - MassLive.com
Pharmaceutical Sterility Testing Market to Drive Revenue to USD 3.79 Billion by 2032 | CAGR 11.58% - GlobeNewswire Inc.
Charles River Laboratories International, Inc. (NYSE:CRL) Holdings Decreased by Victory Capital Management Inc. - MarketBeat
Entropy Technologies LP Reduces Position in Charles River Laboratories International, Inc. (NYSE:CRL) - MarketBeat
Entropy Technologies LP Trims Holdings in Charles River Laboratories International, Inc. (NYSE:CRL) - MarketBeat
Empower Advisory Group LLC Sells 3,497 Shares of Charles River Laboratories International, Inc. (NYSE:CRL) - MarketBeat
Charles River Labs to close Skokie office - Crain's Chicago Business
Charles River Laboratories To Present At UBS Global Healthcare Conference; Webcast At 1:15 PM ET - Nasdaq
Charles River Laboratories International, Inc. (NYSE:CRL) Shares Purchased by WCM Investment Management LLC - MarketBeat
Charles River Laboratories International, Inc. (NYSE:CRL) Position Lowered by Amalgamated Bank - MarketBeat
Genotoxicity Tests Market Trends Detailed Research and Projected Growth through 2032 - WICZ
Charles River Laboratories International (NYSE:CRL) Stock Price Expected to Rise, TD Cowen Analyst Says - MarketBeat
Charles River (CRL) International Revenue in Focus: Trends and Expectations - Yahoo Finance
Charles River Labs to Present Strategic Updates at UBS and Jefferies Healthcare Events | CRL Stock News - StockTitan
Shareholders Can't Ignore US$5.2m Of Sales By Charles River Laboratories International Insiders - Simply Wall St
William Blair Brokers Decrease Earnings Estimates for CRL - MarketBeat
Jensen Investment Management Inc. Decreases Stock Position in Charles River Laboratories International, Inc. (NYSE:CRL) - MarketBeat
Wellington Management Group LLP's Strategic Acquisition in Charles River Laboratories - GuruFocus.com
Charles River Laboratories International, Inc. (NYSE:CRL) Q3 2024 Earnings Call Transcript - Insider Monkey
Charles River Laboratories International Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
Earnings call: Charles River Laboratories reports Q3 2024 results - Investing.com
Evercore ISI Issues Positive Forecast for Charles River Laboratories International (NYSE:CRL) Stock Price - MarketBeat
CLSA Upgrades Charles River Laboratories International (NYSE:CRL) to Hold - MarketBeat
Charles River Labs Raises Profit Outlook After Strong Quarter - Finimize
Five things you need to know, and a lesson from presidential history - The Business Journals
Animal Model Market Generated Opportunities, Future Scope - openPR
Van ECK Associates Corp Cuts Stock Position in Charles River Laboratories International, Inc. (NYSE:CRL) - MarketBeat
Charles River Laboratories International Inc (CRL) Q3 2024 Earni - GuruFocus.com
Decoding Charles River Laboratories International Inc (CRL): A S - GuruFocus.com
Charles River Earnings: Headwinds From Reduced Client Spending; Positive Long-Term Outlook - Morningstar
Charles River Laboratories International Inc (CRL) Q3 2024 Earnings Call Highlights: Navigating ... - Yahoo Finance UK
Charles River Laboratories Announces Third-Quarter 2024 Results - citybiz
Decoding Charles River Laboratories International Inc (CRL): A Strategic SWOT Insight - Yahoo Finance
Charles River Laboratories Reports 2024 Q3 Financial Results - TipRanks
Charles River Laboratories Q3 2024 Earnings Preview - MSN
Charles River: Q3 Earnings Snapshot - The Washington Post
Charles River Laboratories International Inc (CRL) Stock Price U - GuruFocus.com
Massachusetts-based Charles River Labs cuts 1,300 workers, will close over a dozen sites - NBC Boston
Charles River Labs cuts 1,300 workers; will close more than a dozen sites - The Business Journals
Charles River's Q3 Earnings, Revenues Beat Estimates, Margins Fall - Yahoo Finance
Why Is Charles River Laboratories Stock Trading Higher On Wednesday?Charles River (NYSE:CRL) - Benzinga
Charles River (CRL) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates - Yahoo Finance
Charles River Laboratories International, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 28, 2024 - Marketscreener.com
Charles River Laboratories International (NYSE:CRL) Releases FY 2024 Earnings Guidance - MarketBeat
Charles River Laboratories International Q3 24 Earnings Conference Call At 9:30 AM ET - Nasdaq
Charles River Laboratories International Inc Stock (CRL) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.78%
1.36%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):